Log in
A+ A A-

Monkeypox: Concern in Europe after case in Sweden

Featured Monkeypox: Concern in Europe after case in Sweden

The worst fears of a potential spread of monkeypox from the African countries where it originated to the rest of the world have been confirmed by the World Health Organization’s announcement of the first case in a European country, specifically in Sweden.

“The confirmation of Clade 1 mpox in Sweden clearly reflects the interconnectedness of our world (…) It is likely that more imported cases of Clade 1 will be recorded in the European region in the coming days and weeks,” stated the World Health Organization.

The first case in Europe is an individual who “was infected while staying in an area of Africa where a significant mpox outbreak of Clade 1 is occurring,” as clarified in a press conference by Olivia Wigtzell, the interim head of the Swedish Public Health Authority.

Nordic: We Can Prepare 10 Million Vaccines

Meanwhile, just hours after the WHO declared a high-alert status for monkeypox, the pharmaceutical company Bavarian Nordic announced that it is ready to produce 10 million doses of the vaccine by the end of 2025.

“We have the capability to produce 2 million doses in 2024 and a total of 10 million doses by the end of 2025,” the company’s vice president told the French Press Agency.

However, he quickly added that they would wait for orders from interested countries before scaling up vaccine production, saying, “We need to see the vaccines first.” Currently, the company claims to have a stockpile of 500,000 doses.

According to international media, the company’s stock, whose mpox vaccines have been licensed since 2019, rose by up to 8% on the Copenhagen stock exchange on Thursday, following a 12% increase on Wednesday.

Tagged under

News for

Tools

About Us

Follow Us